Ascent Pharmaceuticals recalls 100-count hydrocodone/acetaminophen tablets due to product mix-up. This Rx-only medication may contain incorrect ingredients. Consumers should contact the manufacturer for details.
📍Recalling firmAscent Pharmaceuticals, Inc.400 S Technology Dr · Central Islip, NY 11722-4402
✎ GovInfoNow plain-language explainer
Ascent Pharmaceuticals is recalling 100-count hydrocodone bitartrate and acetaminophen tablets (10 mg/325 mg) that were manufactured for Camber Pharmaceuticals. The recall is due to a product mix-up, meaning the tablets might contain incorrect ingredients. This is a prescription-only medication that could pose risks if the wrong medication is taken. Read more at govinfonow.com/recall/35527-ascent-hydrocodone-acetaminophen-tablets-recall-product-mix-up-hazard.
“Ascent Hydrocodone/Acetaminophen Tablets Recall: Product Mix-Up Hazard.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/35527-ascent-hydrocodone-acetaminophen-tablets-recall-product-mix-up-hazard. Based on FDA recall #D-0276-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0276-2022%22&limit=1).
The FDA announced on November 19, 2021, that Ascent Pharmaceuticals, Inc. voluntarily recalled Hydrocodone Bitartrate and Acetaminophen Tablets due to a product mix-up hazard. The recall affects 9,744 bottles distributed nationwide.
How to tell if you have it
Brand: Ascent Pharmaceuticals
Product: Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/325 mg
Packaging: 100-count bottle, Rx only
Manufactured for: Camber Pharmaceuticals, Inc.
NDC: 31722-997-01
Lot #: 21070817
Expiration: 6/2023
The hazard
The recall was initiated because the product contained a mix-up. The FDA classified this as a Class II recall.
Context
GovInfoNow's records show Ascent Pharmaceuticals, Inc. has two other recalls on record since January 22, 2018. On October 26, 2020, the company recalled Hydrocodone Tablets after foreign Losartan tablets were found in one bottle. Other recent recalls of similar products include American Health Packaging Buprenorphine Tablets Recall (August 19, 2026), Alvogen Thyro-Tabs 150mcg Tablets Recall (December 31, 2025), and Sun Pharmaceutical Perampanel 6mg Tablets Recall (June 17, 2026).
How to tell if you have this one
Check for the 100-count bottle labeled 'Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/325 mg'. Look for the lot number 21070817 on the packaging. This product was manufactured for Camber Pharmaceuticals and sold through prescription.
Brand
Ascent Pharmaceuticals
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Medication Details
Verify the product label includes the lot number 21070817 and the manufacturer information for Camber Pharmaceuticals.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “USA Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 2 years after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0276-2022 (November 19, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0276-2022 to see it in context.
Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.